Literature DB >> 19661087

Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach.

Robert Y L Zee1, Amy J Castonguay, Nathaniel S Barton, Julie E Buring.   

Abstract

Recent studies have shown telomere length shortening in colorectal carcinoma (CRC). However, to date, no prospective, epidemiologic data are available on examining mean leukocyte telomere length as a risk predictor. Using leukocyte DNA samples collected at baseline in a prospective cohort of 14,916 initially healthy American men, we examined the relationship of mean telomere repeat copy number to single gene copy number (T/S ratio), using a modified quantitative PCR protocol, among 191 incident CRC cases (all white males), matched to 306 controls by age, smoking status, and length of follow-up. An inverse correlation between T/S ratio and age was observed in our sample population (P = 0.038). However, the T/S ratios were similar between cases and controls (P = 0.650). Furthermore, in a multivariable adjusted analysis, we found no evidence for an association of the observed T/S ratios with CRC risk (adjusted odds ratio, 1.249; 95% confidence interval, 0.863-1.808; P = 0.238). In summary, the present investigation found no evidence for an association of leukocyte mean telomere length with risk of incident CRC and further suggests that leukocyte mean telomere length may not be a useful indicator for risk assessment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661087      PMCID: PMC2774215          DOI: 10.1158/1055-9965.EPI-09-0360

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

Review 1.  Role of oxidative stress in telomere length regulation and replicative senescence.

Authors:  T von Zglinicki
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

2.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

3.  Physicians' health study: aspirin and primary prevention of coronary heart disease.

Authors: 
Journal:  N Engl J Med       Date:  1989-12-28       Impact factor: 91.245

4.  Telomere reduction in human colorectal carcinoma and with ageing.

Authors:  N D Hastie; M Dempster; M G Dunlop; A M Thompson; D K Green; R C Allshire
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

5.  Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.

Authors:  J Ma; M J Stampfer; E Giovannucci; C Artigas; D J Hunter; C Fuchs; W C Willett; J Selhub; C H Hennekens; R Rozen
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

6.  Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach.

Authors:  Robert Y L Zee; Sherri E Michaud; Soren Germer; Paul M Ridker
Journal:  Clin Chim Acta       Date:  2009-02-13       Impact factor: 3.786

7.  Cellular turnover of normal gastrointestinal epithelium assessed by changes in telomeric: total DNA signal ratios.

Authors:  Wendy L Craig; Alastair McKinlay; Mark A Vickers
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-11       Impact factor: 2.566

8.  Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.

Authors:  Ralf Gertler; Robert Rosenberg; Dominik Stricker; Jan Friederichs; Axel Hoos; Martin Werner; Kurt Ulm; Bernhard Holzmann; Hjalmar Nekarda; Joerg-Ruediger Siewert
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

Review 9.  Genomic instability and cancer.

Authors:  George S Charames; Bharati Bapat
Journal:  Curr Mol Med       Date:  2003-11       Impact factor: 2.222

10.  Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.

Authors:  M Engelhardt; J Albanell; P Drullinsky; W Han; J Guillem; H I Scher; V Reuter; M A Moore
Journal:  Clin Cancer Res       Date:  1997-10       Impact factor: 12.531

View more
  38 in total

Review 1.  Epidemiologic evidence for a role of telomere dysfunction in cancer etiology.

Authors:  Jennifer Prescott; Ingrid M Wentzensen; Sharon A Savage; Immaculata De Vivo
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

2.  Telomere length and telomerase activity; a Yin and Yang of cell senescence.

Authors:  Mary Derasmo Axelrad; Temuri Budagov; Gil Atzmon
Journal:  J Vis Exp       Date:  2013-05-22       Impact factor: 1.355

3.  Telomere length and Parkinson's disease in men: a nested case-control study.

Authors:  M Schürks; J Buring; R Dushkes; J M Gaziano; R Y L Zee; T Kurth
Journal:  Eur J Neurol       Date:  2013-09-07       Impact factor: 6.089

4.  Telomere length varies by DNA extraction method: implications for epidemiologic research.

Authors:  Julie M Cunningham; Ruth A Johnson; Kristin Litzelman; Halcyon G Skinner; Songwon Seo; Corinne D Engelman; Russell J Vanderboom; Grace W Kimmel; Ronald E Gangnon; Douglas L Riegert-Johnson; John A Baron; John D Potter; Robert Haile; Daniel D Buchanan; Mark A Jenkins; David N Rider; Stephen N Thibodeau; Gloria M Petersen; Lisa A Boardman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-09       Impact factor: 4.254

5.  Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.

Authors:  Shaogui Wan; Hie-Won Hann; Zhong Ye; Richard S Hann; Yinzhi Lai; Chun Wang; Ling Li; Ronald E Myers; Bingshan Li; Jinliang Xing; Hushan Yang
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

6.  Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.

Authors:  Andrew J Pellatt; Roger K Wolff; Abbie Lundgreen; Richard Cawthon; Martha L Slattery
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

7.  No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.

Authors:  Karen A Pooley; Jonathan Tyrer; Mitul Shah; Kristy E Driver; Jean Leyland; Judith Brown; Tina Audley; Lesley McGuffog; Bruce A J Ponder; Paul D P Pharoah; Douglas F Easton; Alison M Dunning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

8.  Telomere length in prospective and retrospective cancer case-control studies.

Authors:  Karen A Pooley; Manjinder S Sandhu; Jonathan Tyrer; Mitul Shah; Kristy E Driver; Robert N Luben; Sheila A Bingham; Bruce A J Ponder; Paul D P Pharoah; Kay-Tee Khaw; Douglas F Easton; Alison M Dunning
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

9.  Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study.

Authors:  I-Min Lee; Jennifer Lin; Amy J Castonguay; Nathaniel S Barton; Julie E Buring; Robert Y L Zee
Journal:  Clin Chem Lab Med       Date:  2010-02       Impact factor: 3.694

10.  Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study.

Authors:  Yong Cui; Qiuyin Cai; Shimian Qu; Wong-Ho Chow; Wanqing Wen; Yong-Bing Xiang; Jie Wu; Nathaniel Rothman; Gong Yang; Xiao-Ou Shu; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-21       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.